Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity.

Authors: Pajarillo, Edward; Johnson Jr, James; Rizor, Asha; Nyarko-Danquah, Ivan; Adinew, Getinet; Bornhorst, Julia; Stiboller, Michael; Schwerdtle, Tania; Son, Deok-Soo; Aschner, Michael; Lee, Eunsook

Published In J Biol Chem, (2020 Nov 13)

Abstract: Manganese (Mn)-induced neurotoxicity resembles Parkinson's disease (PD), but the mechanisms underpinning its effects remain unknown. Mn dysregulates astrocytic glutamate transporters, GLT-1 and GLAST, and dopaminergic function, including tyrosine hydroxylase (TH). Our previous in vitro studies have shown that Mn repressed GLAST and GLT-1 via activation of transcription factor Yin Yang 1 (YY1). Here, we investigated if in vivo astrocytic YY1 deletion mitigates Mn-induced dopaminergic neurotoxicity, attenuating Mn-induced reduction in GLAST/GLT-1 expression in murine substantia nigra (SN). AAV5-GFAP-Cre-GFP particles were infused into the SN of 8-week-old YY1 flox/flox mice to generate a region-specific astrocytic YY1 conditional knockout (cKO) mouse model. 3 weeks after adeno-associated viral (AAV) infusion, mice were exposed to 330 μg of Mn (MnCl2 30 mg/kg, intranasal instillation, daily) for 3 weeks. After Mn exposure, motor functions were determined in open-field and rotarod tests, followed by Western blotting, quantitative PCR, and immunohistochemistry to assess YY1, TH, GLAST, and GLT-1 levels. Infusion of AAV5-GFAP-Cre-GFP vectors into the SN resulted in region-specific astrocytic YY1 deletion and attenuation of Mn-induced impairment of motor functions, reduction of TH-expressing cells in SN, and TH mRNA/protein levels in midbrain/striatum. Astrocytic YY1 deletion also attenuated the Mn-induced decrease in GLAST/GLT-1 mRNA/protein levels in midbrain. Moreover, YY1 deletion abrogated its interaction with histone deacetylases in astrocytes. These results indicate that astrocytic YY1 plays a critical role in Mn-induced neurotoxicity in vivo, at least in part, by reducing astrocytic GLAST/GLT-1. Thus, YY1 might be a potential target for treatment of Mn toxicity and other neurological disorders associated with dysregulation of GLAST/GLT-1.

PubMed ID: 32893191 Exiting the NIEHS site

MeSH Terms: Animals; Astrocytes/cytology; Astrocytes/metabolism; Chlorides/toxicity; Down-Regulation/drug effects; Excitatory Amino Acid Transporter 1/genetics; Excitatory Amino Acid Transporter 1/metabolism; Excitatory Amino Acid Transporter 2/genetics; Excitatory Amino Acid Transporter 2/metabolism; Female; Histone Deacetylases/metabolism; Locomotion/drug effects; Male; Manganese Compounds; Manganese Poisoning/metabolism; Manganese Poisoning/pathology*; Mice; Mice, Knockout; RNA, Messenger/metabolism; Substantia Nigra/metabolism*; Tyrosine 3-Monooxygenase/genetics; Tyrosine 3-Monooxygenase/metabolism; YY1 Transcription Factor/genetics; YY1 Transcription Factor/metabolism*

to Top